Cargando…
Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth
Colorectal cancer (CRC) is the third most common cancer worldwide and still lacks effective therapy. Ivermectin, an antiparasitic drug, has been shown to possess anti-inflammation, anti-virus, and antitumor properties. However, whether ivermectin affects CRC is still unclear. The objective of this s...
Autores principales: | Zhou, Shican, Wu, Hang, Ning, Wenjuan, Wu, Xiao, Xu, Xiaoxiao, Ma, Yuanqiao, Li, Xingwang, Hu, Junhong, Wang, Chenyu, Wang, Junpeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415024/ https://www.ncbi.nlm.nih.gov/pubmed/34483925 http://dx.doi.org/10.3389/fphar.2021.717529 |
Ejemplares similares
-
Effect of high glucose supplementation on pulmonary fibrosis involving reactive oxygen species and TGF-β
por: Ning, Wenjuan, et al.
Publicado: (2022) -
Is Ivermectin Effective in Treating COVID-19?
por: Yang, Shuangshuang, et al.
Publicado: (2022) -
Fructose Induces Pulmonary Fibrotic Phenotype Through Promoting Epithelial-Mesenchymal Transition Mediated by ROS-Activated Latent TGF-β1
por: Xu, Xiaoxiao, et al.
Publicado: (2022) -
Computational Drug Repositioning and Experimental Validation of Ivermectin in Treatment of Gastric Cancer
por: Rabben, Hanne-Line, et al.
Publicado: (2021) -
Decylubiquinone Inhibits Colorectal Cancer Growth Through Upregulating Sirtuin2
por: Li, Jinlian, et al.
Publicado: (2022)